The Greenwich Biosciences mission is rooted in unlocking the potential of cannabinoid medicines to address serious medical conditions with limited treatment options. Greenwich Biosciences, now a part of Jazz Pharmaceuticals, is the U.S. leader in the field of cannabinoid prescription medicines.